Alabama
Birmingham; University of Alabama at Birmingham
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Arizona
Litchfield Park; Dedicated Clinical Research
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Litchfield Park; Dedicated Clinical Research
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Mesa; Pivotal Research Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Peoria; Pivotal Research Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Scott Dale; Mayo Clinic - Arizona
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Sun City; Sun Health Research Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Sun City; Sun Health Research Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Arkansas
Little Rock; Arkansas Cardiology
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
California
Fountain Valley; The Parkinson's and Movement Disorders Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Irvine; University of California, Irvine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Menlo Park; Omneuron, Inc.
Treatment of Chronic Pain using Real Time functional fMRI
Oxnard; Pacific Neuroscience Medical Group
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Oxnard; Pacific Neuroscience Medical Group, Inc.
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Sunnyvale; The Parkinson's Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Sunnyvale; The Parkinson's Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Florida
Gainesville; Southeastern Integrated Medical
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gainesville; Southeastern Integrated Medical, PL
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Jacksonville; Mayo Jacksonville Department of Neurology
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Jacksonville; Mayo Jacksonville Florida Department of Neurology
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Miami; University of Miami Miller School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Miami; University of Miami Miller School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
St. Petersburg; Suncoast Neuroscience Associates, Inc.
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Tampa; University of South Florida
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
West Bradenton; Bradenton Neurology, Inc
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Illinois
Chicago; Saint Mary of Nazareth Hospital Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Chicago; Saint Mary of Nazareth Hospital Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Chicago; North Chicago VA Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
North Chicago; North Chicago VA Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Indiana
Elkhart; Indiana Medical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Elkhart; Indiana Medical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Indianapolis; GlendaleAdult Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Kansas
Kansas City; University of Kansas Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Overland Park; Kansas City Bone and Joint, PA
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Kentucky
Louisville; University of Louisville
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Louisville; University of Louisville
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Maryland
Baltimore; University of Maryland Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Baltimore; University of Maryland Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Bethesda; CNCS, NINDS, NIH
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Massachusetts
Boston; Beth Israel Deaconess Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Boston; MGH - Massachusetts General Hospital
Clinical Management of Neuropathic Pain with Ramelteon
Boston; Beth Israel Deaconess Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Worcester; University of Massachusetts Worcester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Worcester; University of Massachusetts Worcester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Michigan
Petoskey; Northern Michigan Regional Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Southfield; Henry Ford Health System
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Southfield; Henry Ford Health System - Franklin Pointe
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Minnesota
Rochester; Mayo Clinic Rochester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; Mayo Clinic Rochester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Mississippi
Hattiesburg; Neurological Research Center at Hattiesburg Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Missouri
St. Louis; Washington University Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Nevada
Las Vegas; University of Nevada School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New Jersey
Edison; JFK Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Edison; New Jersey Neuroscience Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York
Manshasette; North Shore Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York; New York University School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York; Columbia University Neurological Institute of NY
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York; Mount Sinai Medical Center
New Approaches for Diagnosis of Neuropathy and Motor Neuron Disease: Biomarker Discovery
New York City; NYU Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York City; Columbia University Neurological Institute of NY
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; University of Rochester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; University of Rochester Neurology
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; Rochester Clinical Research
Diabetes / Neuropathy
Ohio
Cincinnati; University of Cincinnati
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Cleveland; University Hospitals Case Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Cleveland; Cleveland Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Cleveland; University Hospitals Case Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Cleveland; Cleveland Clinic Foundation
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Oklahoma
Oklahoma City; COR Clinical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Oklahoma City; COR Clinical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Pennsylvania
Philadelphia; Pennsylvania Hospital of the University of PA Health System
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Upland; HAN Neurological Associates
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Tennessee
Nashville; Vanderbilt University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Nashville; Vanderbilt University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Texas
Dallas; UT Southwestern Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Dallas; UT Southwestern Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Houston; Baylor College of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Tyler; East Texas Medical Center - Neurological Institute Movement Disorders Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Washington
Kirkland; Evergreen Hospital Medical Center; Booth Gardner Parkinson's Care Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
International
Adelaide, Australia; Royal Adelaide Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Heidelberg, Australia; Austin Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Melbourne, Australia; Baker Heart Research Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Calgary, Alberta, Canada; University of Calgary
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Edmonton, AB, Canada; University of Alberta
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Halifax, NS, Canada; David B King, MD Private Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Hamilton, Ontario, Canada; McMaster University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
London, ON, Canada; London Health Sciences Centre, UH
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Markham, Ontario, Canada; Centre for Movement Disorders
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Markham, Ontario, Canada; Centre for Movement Disorders
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Markham, Ontario, Canada; McMaster University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Markham, Ontario, Canada; Quebec Memory and Motor Skills Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Montreal, QC, Canada; Department of Neurology SMBD Jewish General Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Montreal, Quebec, Canada; SMBD Jewish General Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Montreal, Quebec, Canada; Institut de recherches cliniques de Montreal
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Ottawa, ON, Canada; Parkinson's & Neurodegenerative Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Ottawa, Ontario, Canada; Parkinson's & Neurodegenerative Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Quebec City, Quebec, Canada; Quebec Memory and Motor Skills Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Toronto, Ontario, Canada; UHNresearch
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Winnipeg, Manitoba, Canada; Movement Disorder Clinic Deer Lodge Centre
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Christchurch, New Zealand; Van der Veer Institute for Parkinson's Disease and Movement Disorders
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
GRAFTON AUCKLAND, New Zealand; Auckland Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Katowice, Poland; Klinika Neurologii Wieku Podeszlego
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Katowice, Poland; Niepubliczny Zaklad Opieki
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Krakow, Poland; Centrum Neurologii Klinicznej
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Warszawa, Poland; Samodzielny Publiczny Central
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Bristol, United Kingdom; Frenchay Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Exeter, United Kingdom; Royal Devon & Exeter Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Ipswich, Suffolk
Bury, United Kingdom; Dept. of Neurology Ipswich Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Lancashire
Bury, United Kingdom; Fairfield General Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
London, United Kingdom; Imperial School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Newcastle-upon-Tyne, United Kingdom; Newcastle General Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Northampton
Bury, United Kingdom; Dept. of Neurology, Northampton General Hospital NHS trust
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Peterborough
Bury, United Kingdom; Medicine for the Elderly
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
